ECONOMIC EXPENDITURES IN THE PHARMACY MANUFACTURING OF INFUSION SOLUTIONS

Introduction. The reduction in the production activities of pharmacies due to the ban on the manufacturing of medicines registered in the Russian Federation and produced by the pharmaceutical industry has resulted in increasing the burden on the budget of healthcare facilities that purchase these drugs on the market. The hypothesis for that the manufacture of infused drugs by the pharmacies of healthcare facilities for their own needs may be now economically feasible compared with the costs of their procurement has been made. Objective: to calculate the economic expenditures that form the cost price of infusion solutions during pharmacy manufacturing, to compare the cost price with the purchasing one of similar drugs manufactured by the industry, and to identify reserves for enhancing the efficiency of production activities of pharmacies. Material and methods. Methods for documentary observation, analysis of the chemical-technological system of production processes, and timing observations were used. Results. The values of material, utility, and labor costs were determined, the total value of which amounted to the cost of 7 names of infusion solutions selected as investigation objects. Comparison of the cost price of manufactured drugs and the purchasing prices of their analogues produced by the industry revealed that the pharmacy manufacturing was not really economically profitable for the entire range of test infused drugs under the existing conditions. Conclusion. To enhance the economic efficiency of the pharmacy manufacturing of infusion solutions, it is necessary to reduce material costs, by coming to the use of a polymer consumer container and by equipping the pharmacies of multidisciplinary healthcare facilities with modern technological complexes for the manufacture of infused drugs.

medicines, infusion solutions, pharmacy manufacturing, economic expenditures